Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Clinical trial NCT00725062 · TERMINATED

Trial details

NCT number: NCT00725062
Sponsor: Masonic Cancer Center, University of Minnesota
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes

Start date: 2008-06-01
Primary completion: 2010-04-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.